Profile
Mr. Des H.
O’Connell, Jr. MBA, is an Advisor at Mi3 Venture Partners Management LLC.
He currently serves as Chairman of the Board of Serologicals, which he joined as interim CEO in 1999.
He is also a Director of Abiomed and a member of the audit committee.
Previously, he was Chairman and CEO of Osteotech, a global leader in the processing of human bone and connective tissue for transplantation.
He serves as Chairman of the Board of VueSonix Sensors, a Mi3 portfolio company.
Prior to Osteotech, Mr. O’Connell held several executive positions within the healthcare division of the BOC Group.
He joined BOC Health Care from Baxter International, where his roles included President, International Division (with over 7,000 employees), CEO of the Therapeutic and Diagnostics Division, and finally Vice President of Corporate development.
Mr. O’Connell began his career at McKinsey and Company.
He holds an M.B.A.
from Harvard Business School and a B.S.
in Electrical Engineering from the University of Notre Dame.
Former positions of Des H. O’Connell
Companies | Position | End |
---|---|---|
ABIOMED, INC. | Director/Board Member | 2011-05-08 |
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Director/Board Member | 2008-06-30 |
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Chairman | 2006-04-30 |
Chrysalis International Corp.
Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Director/Board Member | 1999-04-30 |
Pharmakon Research International, Inc. | Corporate Officer/Principal | 1993-11-30 |
Training of Des H. O’Connell
Harvard University | Masters Business Admin |
University of Notre Dame | Undergraduate Degree |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
Private companies | 13 |
---|---|
StemCells, Inc.
StemCells, Inc. BiotechnologyHealth Technology StemCells, Inc. engages in the research, development and commercialization of stem cell therapeutics and related tools and technologies for academia and industry. The company is focused on developing and commercializing stem and progenitor cells as the basis for novel therapeutics and therapies; and cells and related tools and technologies to enable stem cell-based research and drug discovery and development. StemCells research and development efforts are focused on identifying and developing stem and progenitor cells as potential therapeutic agents. The company was founded by David J. Anderson and Fred H. Gage in August 1988 and is headquartered in Newark, CA. | Health Technology |
New Community Corp.
New Community Corp. Miscellaneous Commercial ServicesCommercial Services New Community Corp. engages in providing services to help residents of inner cities improve the quality of their lives. Its services include education and youth services, transitional living and family services, extended care and mental health, real estate and development operations. The company was founded in 1968 William J. Linder and is headquartered in Newark, NJ. | Commercial Services |
ABIOMED, Inc.
ABIOMED, Inc. Medical SpecialtiesHealth Technology ABIOMED, Inc. engages in the research, development, and sale of medical devices to assist or replace the pumping function of the failing heart. It distributes its products under the Impella brand. The company was founded by David M. Lederman in 1981 and is headquartered in Danvers, MA. | Health Technology |
VueSonix Sensors, Inc.
VueSonix Sensors, Inc. Medical/Nursing ServicesHealth Services VueSonix Sensors, Inc. develops medical imaging equipment. It develops vascular imaging, diagnosis, and monitoring systems using ultrasound as an enabling media. The company was founded in 1999 and is headquartered in Wayne, PA. | Health Services |
Pharmakon Research International, Inc. | |
Osteotech, Inc.
Osteotech, Inc. Medical SpecialtiesHealth Technology Osteotech, Inc. develops biologic products for orthopedic, spinal, trauma, neurosurgical, and maxillofacial surgeons for use in surgical procedures. It operates in five segments: demineralized bone matrix, hybrid/synthetic, traditional tissue, spinal allograft, and client services. The company processes, markets, and distributes Xenograft bone tissue products, which are used as bone graft substitutes. The company was founded in 1986 and is headquartered in Eatontown, NJ. | Health Technology |
Baxter Laboratories, Inc. | |
The BOC Group Ltd.
The BOC Group Ltd. Chemicals: SpecialtyProcess Industries The BOC Group Ltd. manufactures industrial special gases, vacuum pumps, and components. It provides vacuum technologies, distribution services and solutions to the global electronics packaging industry. The company is headquartered in Surrey, United Kingdom. | Process Industries |
Ohmeda
Ohmeda Pharmaceuticals: OtherHealth Technology Part of Atlas Copco AB, Ohmeda is a British company that manufactures equipment goods and gas pipeline systems. The company is based in Surrey, UK. Ohmeda was acquired by Atlas Copco Medical Ltd. on January 01, 1995 for $40.52 million. | Health Technology |
Chrysalis International Corp.
Chrysalis International Corp. Pharmaceuticals: MajorHealth Technology Chrysalis International Corp. provides drug development services to the pharmaceutical and biotechnology industries. Its services include transgenic discovery research, preclinical development and clinical capabilities. The company was founded in 1988 and is headquartered in Raritan, NJ. | Health Technology |
Serologicals Corp.
Serologicals Corp. Miscellaneous Commercial ServicesCommercial Services Serologicals Corp. researches, develops and markets biological products for the life sciences market. The firm focuses in areas such as are cell culture supplements, molecular reagents and diagnostic antibodies. Its applications include cardiology, hematology, infectious diseases, immunology, molecular biology and oncology. It has operations in Australia, Canada, Scotland, and United Kingdom. The company was founded in 1971 by Samuel A. Penninger and is located in Norcross, GA. | Commercial Services |
Amorcyte, Inc.
Amorcyte, Inc. Miscellaneous Commercial ServicesCommercial Services Amorcyte, Inc. provides cell therapy product development services. It focuses on developing cell therapeutics for cardiovascular disease. The company was founded by Andrew L. Pecora in 2004 and is headquartered in Allendale, NJ. | Commercial Services |
McKinsey & Co., Inc.
McKinsey & Co., Inc. Miscellaneous Commercial ServicesCommercial Services McKinsey & Co., Inc. provides management consulting services. It specializes in design, marketing and sales, analytics, operations, transformation and restructuring, risk, strategy and corporate finance, and sustainability and resource productivity. The company was founded by James O. McKinsey in 1926 and is headquartered in New York, NY. | Commercial Services |
- Stock Market
- Insiders
- Des H. O’Connell